Checking TRVI unusual options activity helps you spot when traders are making outsized bets on Trevi Therapeutics Inc before the broader market catches on. Trevi Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor TRVI unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching TRVI unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking TRVI unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and TRVI unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Catalysts rarely arrive without a footprint, and TRVI unusual options activity is often where that footprint shows up first. Our scanner tracks Trevi Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at TRVI unusual options volume on the call side or chasing put sweeps, Trevi Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
